By Nichola Saminather
By Nichola Saminather
TORONTO, Dec 18 (Reuters) – Aurora Hashish Inc ACB.TO this week grew to become the primary main Canadian firm to promote edibles and vapes for medical use, a small base that however helps shore up margins and paves the best way for gross sales within the a lot bigger European medical market.
Medical marijuana has been authorized in Canada since 2001, and leisure use since October 2018, however derivatives – merchandise from hashish extracts, like edibles – have been solely authorised for gross sales this week for each medical and leisure use.
“Should you’re trying to launch a product into markets like Denmark or Germany, you might be required to be promoting it within the medical market in Canada first,” mentioned Deepak Anand, chief govt of Materia Ventures, a Europe-focused hashish distribution firm.
Aurora govt Cam Battley acknowledged this was a consideration in boosting its medical menu.
Canada’s second-biggest marijuana producer added…